Expertise in
5
conditions

Vilius Rudaitis

M. K. Čiurlionio Str. 21/27, 
Vilnius, VL, LT 
Expertise in
5
conditions
M. K. Čiurlionio Str. 21/27, 
Vilnius, VL, LT 

Overview

Vilius Rudaitis practices practicing medicine in Vilnius, Lithuania.

Rudaitis is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Ovarian Cancer, Leydig Cell Testicular Tumor, Sertoli-Leydig Cell Tumor, Oophorectomy, and Salpingo-Oophorectomy.

They are actively involved in clinical research, co-authoring 34 peer reviewed articles and participating in 1 clinical trial.

Locations

M. K. Čiurlionio Str. 21/27, Vilnius, VL LT03101, Lithuania
Other Locations
M.K. Ciurlionio Str. 21, Vilnius, VL LT03101, Lithuania
Santariskiu St. 2, Vilnius, VL, Lithuania
M. K. Čiurlionio Street 21, Vilnius, VL 03101, Lithuania

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1/2, Open-Label, Multiple Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion to Second Line Cervical Cancer
A Phase 1/2, Open-Label, Multiple Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion to Second Line Cervical Cancer
Enrollment Status: Completed
Publish Date: July 30, 2025
Intervention Type: Drug
Study Drug: AGEN-2034 PD-1 Antibody
Study Phase: Phase 1/Phase 2

34 Total Publications

Additional sectioning and AI-assisted diagnosis reveal underdiagnosis of serous (pre)malignancies in fallopian tube specimen from BRCA1/2 carriers.
Additional sectioning and AI-assisted diagnosis reveal underdiagnosis of serous (pre)malignancies in fallopian tube specimen from BRCA1/2 carriers.
Journal: Histopathology
Published: May 20, 2026

Frequently Asked Questions about Vilius Rudaitis

Is Vilius Rudaitis a top-rated expert for Ovarian Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Vilius Rudaitis is classified as an Advanced expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vilius Rudaitis participate in research or clinical trials?

Yes. Vilius Rudaitis has published 34 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Vilius Rudaitis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Rudaitis's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile